A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study

OBJECTIVE: To describe whether contemporary dosing of antifungal drugs achieves therapeutic exposures in critically ill patients that are associated with optimal outcomes. Adequate antifungal therapy is a key determinant of survival of critically ill patients with fungal infections. Critical illness...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Jason A., Sime, Fekade, Lipman, Jeffrey, Hernández-Mitre, Maria Patricia, Baptista, João Pedro, Brüggemann, Roger J., Darvall, Jai, De Waele, Jan J., Dimopoulos, George, Lefrant, Jean-Yves, Mat Nor, Mohd Basri, Rello, Jordi, Seoane, Leonardo, Slavin, Monica A., Valkonen, Miia, Venditti, Mario, Wong, Wai Tat, Zeitlinger, Markus, Roger, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581271/
https://www.ncbi.nlm.nih.gov/pubmed/37876989
http://dx.doi.org/10.1016/j.ccrj.2023.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581271/
https://www.ncbi.nlm.nih.gov/pubmed/37876989
http://dx.doi.org/10.1016/j.ccrj.2023.04.002

Ejemplares similares